We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?
- Authors
El‐Galaly, Tarec Christoffer; Glimelius, Ingrid
- Abstract
Hodgkin lymphoma is among the most curable cancers. For patients in remission for 24 months, residual lifetime becomes close to that of the background population. However, late relapses can occur after several years and, as shown by Andersen et al., the outcomes are not always good. Commentary on: Andersen MD, Hamilton‐Dutoit S, Modvig L, Vase M, Christiansen I, Christensen JH, et al. Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma – A study from the Danish Lymphoma Registry. Br J Haematol 2022;198:50‐61.
- Subjects
HODGKIN'S disease; CANCER treatment; LYMPHOMAS
- Publication
British Journal of Haematology, 2022, Vol 198, Issue 1, p11
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.18199